These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1121805)

  • 1. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
    Iakumova NIa; Ivanova AV; Sukhanov AA
    Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
    Rass IT; Borisov IA; Nikishova TA; Sura VV
    Ter Arkh; 1977; 49(8):110-5. PubMed ID: 929380
    [No Abstract]   [Full Text] [Related]  

  • 3. [Systemic erythematosus--the blood].
    Yamaguchi H
    Nihon Rinsho; 1968 Dec; 26(12):3426-9. PubMed ID: 5753024
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraplatelet and urinary serotonin concentrations in systemic lupus erythematosus with reference to its clinical manifestations.
    Kanai H; Tsuchida A; Yano S; Naruse T
    J Med; 1989; 20(5-6):371-90. PubMed ID: 2534129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
    Oshimi K; Gonda N; Sumiya M; Kano S
    Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The thrombocyte link in blood-coagulation homeostasis in patients with systemic lupus erythematosus].
    Vas'kova NG
    Vrach Delo; 1990 Nov; (11):51-3. PubMed ID: 2098984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change in the amino acid spectrum of the blood serum in patients with lupus erythematosus under the effect of therapy].
    Pavlova LT
    Vestn Dermatol Venerol; 1970 Jul; 44(7):11-4. PubMed ID: 5511088
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
    Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
    Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and laboratory observations in eight patients with lupus-type circulating anticoagulant.
    Canciani MT; Maspero ML; Cattaneo M; Mannucci PM
    Haematologica; 1979 Jun; 64(3):309-21. PubMed ID: 113299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of a platelet factor 3 immunoinjury technique in the detection of antiplatelet antibody in systemic lupus erythematosus and other clinical disorders.
    Kutti J; Safai-Kutti S
    Scand J Rheumatol; 1978; 7(1):17-20. PubMed ID: 353972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discontinuous corticosteroid treatment of systemic lupus erythematosus].
    Tareeva IE
    Klin Med (Mosk); 1972 Jun; 50(6):95-9. PubMed ID: 5086287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma coagulation and fibrinolysis in systemic lupus erythematosus (author's transl)].
    Arnalich Fernández F; Gil Aguado A; Enríquez L; Navarro JL; Barbado Hernández FJ; Vázquez Rodríguez JJ
    Med Clin (Barc); 1979 Jun; 73(1):5-10. PubMed ID: 470505
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
    Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
    [No Abstract]   [Full Text] [Related]  

  • 17. [Objective evaluation of remote results of treatment of systemic lupus erythematosus].
    Ivanova MM; Nasonova VA; Folomeeva OM; Speranskiĭ AI; Kozlova VN
    Ter Arkh; 1977; 49(9):60-6. PubMed ID: 929421
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prednisolone sensitivity of peripheral blood mononuclear cells of patients with systemic lupus erythematosus clinically resistant to glucocorticoids and the effects of carbon hemoperfusion].
    Petrova GN; Baranova FS; Popova LK; Dmitriev AA
    Ter Arkh; 1987; 59(8):107-10. PubMed ID: 3686432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
    Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombokinetics in systemic lupus erythematosus A preliminary report.
    Bergström AL; Kutti J; Safai-Kutti S
    Pahlavi Med J; 1976 Apr; 7(2):180-94. PubMed ID: 1272594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.